Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signalingR. P. Tripathi, Rina Plattner, Aditi Jain et al.|Nature Communications|2020Cited by 51